Test Price
2,800 AED✅ Home Collection Available
HNF1A Germline Mutation Genetic Test for Renal Cell Carcinoma (NGS) in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with genetic counselor interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
This advanced genetic test employs Next-Generation Sequencing to identify inherited mutations in the HNF1A gene that confer a significantly elevated lifetime risk of renal cell carcinoma. The test is recommended for individuals with a personal or family history of kidney cancer, enabling precise cancer surveillance and risk-reduction strategies. Mandatory pre-test genetic counselling ensures complete understanding of the implications.
Test Overview & Methodology
The HNF1A Germline Mutation Genetic Test employs Next‑Generation Sequencing (NGS) to identify inherited mutations in the HNF1A gene that confer a significantly elevated lifetime risk of renal cell carcinoma. This test is recommended for individuals with a personal or family history of kidney cancer, and it empowers precise cancer surveillance and risk‑reduction strategies.
| Feature | Our Test (HNF1A NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full coding region and splice sites | Sanger sequencing of selected exons only |
| Detection Rate | >99.9% for SNVs, indels, and copy number variants | ~95% for point mutations; misses large rearrangements |
| Turnaround Time | 3 to 4 weeks | 6 to 8 weeks |
| Price | 2,800 AED | 3,500–4,200 AED |
| DHA Compliance | Full DHA/MOHAP standards (Federal Decree-Law No. 45 of 2021 on Personal Data Protection) | May not be locally accredited |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics specialist, I understand the profound anxiety that accompanies hereditary cancer risk assessment. This test does not diagnose active cancer; it reveals a genetic predisposition that must be interpreted within the full context of personal and family medical history. I strongly recommend completing mandatory genetic counselling beforehand and sharing all results with your treating physician to develop a comprehensive risk management plan tailored to your unique clinical profile."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory Precautions
Important Clinical Guidance:
Test results indicate hereditary predisposition only and do not confirm the presence of active malignancy. All findings must be correlated with radiological imaging, histopathological evaluation, and clinical examination by a qualified specialist before any therapeutic decisions are made.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria – Do Not Proceed Without Approval
- Inability or refusal to complete pre‑test genetic counselling
- Lack of informed consent signed by the patient or legal guardian
- Active systemic infection that may compromise DNA sample integrity
- Known interfering condition (e.g., recent chemotherapy affecting circulating DNA – clinician must determine alternative sample type)
- Minors under 18 years without parental consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability
Seek Emergency Medical Attention If:
- Sudden, severe flank or abdominal pain
- Visible blood in urine (hematuria)
- Unexplained, rapid weight loss together with fever
- Palpable abdominal mass
- New‑onset night sweats and persistent fatigue
These symptoms require immediate clinical evaluation, regardless of your genetic test status.
Patient FAQ & Clinical Guidance
- This advanced genetic test analyzes the HNF1A gene for inherited mutations that significantly increase renal cell carcinoma risk. Any individual with a strong family history of kidney cancer, early‑onset renal tumours, or a personal diagnosis of renal cell carcinoma should discuss this test with their oncologist or genetic counsellor. It is also valuable for asymptomatic relatives of known mutation carriers.
- We use whole blood collected via standard venipuncture. Our DHA‑licensed phlebotomists perform hospital‑grade home collections using temperature‑controlled cold‑chain logistics; the sample is processed in an ISO 9001:2015‑accredited molecular laboratory. The method is as reliable as a hospital draw because we enforce strict pre‑analytical controls and maintain chain of custody documentation.
- A positive result indicates you carry a HNF1A mutation that predisposes to renal cell carcinoma, not active cancer. Negative or variant‑of‑uncertain‑significance results require specialist interpretation. Your genetic data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields; it will never be shared without your explicit consent. We provide telephonic post‑test counselling to explain every outcome.
- Yes, pre‑test genetic counselling is mandatory as per Federal Decree-Law No. 4 of 2016 on Medical Liability. The counselling session covers the purpose of the test, potential outcomes including variants of uncertain significance, implications for family members, and your rights regarding data privacy. You will have the opportunity to ask questions and make an informed decision before providing written consent.
- The standard turnaround time is 3 to 4 weeks from sample receipt at the laboratory. Results are delivered via secure encrypted digital portal and discussed during a telephonic post‑test counselling session with our genetic specialist. A printed clinical report suitable for sharing with your treating physician is also provided.
1. What is the HNF1A germline mutation test and who should consider it?
2. How are samples collected, and is home collection reliable?
3. What do the results mean, and how are they protected under UAE law?
4. Is pre-test genetic counselling mandatory, and what does it involve?
5. How long does it take to receive results, and how are they delivered?
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – full data sovereignty and encryption enforced
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – compliant health data handling
- Federal Decree-Law No. 4 of 2016 on Medical Liability – patient safety and informed consent protocols
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) – quality management system audited annually
- DHA Facility License: 1143 – actively registered and compliant with Dubai Health Authority standards
- Laboratory premises located at: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
Clinical & Logistical Metadata
| Test Name | HNF1A Germline Mutation Genetic Test for Renal Cell Carcinoma (NGS) |
| Price (AED) | 2,800 AED (inclusive of pre-test counselling, home collection, and post-test guidance) |
| Turnaround Time | 3 to 4 weeks from sample receipt |
| Sample Type / Matrix | Whole blood (peripheral venipuncture) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) – full coding region and splice site analysis |
| ICD-10-CM Code | C64.9, Z15.09, Z80.51 |
| LOINC Code | 101230-7 (HNF1A gene mutations found) |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians